Varlitinib

CAS No. 845272-21-1

Varlitinib ( ASLAN001;ARRY-334543 )

Catalog No. M19459 CAS No. 845272-21-1

Varlitinib is a selective and potent ErbB1(EGFR) and ErbB2(HER2) inhibitor with IC50 of 7 nM and 2 nM respectively. Phase 2.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 60 Get Quote
5MG 87 Get Quote
10MG 155 Get Quote
25MG 259 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Varlitinib
  • Note
    Research use only not for human use.
  • Brief Description
    Varlitinib is a selective and potent ErbB1(EGFR) and ErbB2(HER2) inhibitor with IC50 of 7 nM and 2 nM respectively. Phase 2.
  • Description
    Varlitinib is a selective and potent ErbB1(EGFR) and ErbB2(HER2) inhibitor with IC50 of 7 nM and 2 nM respectively. Phase 2.
  • Synonyms
    ASLAN001;ARRY-334543
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    EGFR/ErbB1; HER2/ErbB2
  • Research Area
    Cancer
  • Indication
    Biliary Cancer

Chemical Information

  • CAS Number
    845272-21-1
  • Formula Weight
    466.94
  • Molecular Formula
    C22H19ClN6O2S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:6 mg/mL (12.84 mM);Ethanol:<1 mg/mL;Water:<1 mg/mL
  • SMILES
    C[C@@H]1COC(NC2=CC3=C(C=C2)N=CN=C3NC2=CC(Cl)=C(OCC3=NC=CS3)C=C2)=N1
  • Chemical Name
    (R)-N4-(3-chloro-4-(thiazol-2-ylmethoxy)phenyl)-N6-(4-methyl-45-dihydrooxazol-2-yl)quinazoline-46-diamine.

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Miknis G et al. Abstracts #3399.
molnova catalog
related products
  • Pyrotinib maleate

    Pyrotinib maleate (SHR-1258 maleate)is a potent and selective EGFR/HER2 dual inhibitor with IC50 of 13/38 nM, respectively.

  • Varlitinib

    Varlitinib is a selective and potent ErbB1(EGFR) and ErbB2(HER2) inhibitor with IC50 of 7 nM and 2 nM respectively. Phase 2.

  • AZD-9291 mesylate

    A potent, selective, third-generation irreversible inhibitor of mutant EGFR with IC50s of 1/12/5 nM for L858R-T790M/L858R/L861Q respectively.